Reddit Posts
Curious If Anyone Has Thoughts on IBRX (ImmunityBio)
DD (Due Diligence) IN8bio Inc. (NASDAQ: INAB) next IBRX or SLS ?
Do some trading platforms have dodgy algorithms?
$IBRX โ real holder using AI for clarity, not hype. Here's why I think the fundamentals justify the run
$IBRX โ real holder using AI so I don't get details wrong. 40% of the float is short and the company is genuinely great.
The r/pennystocks lounge is DYING - we need to SAVE IT
Trump might cure cancer and IBRX could moon with or without the short squeeze.
$IBRX has catalysts, 37% SI, and a creeping DTC
$IBRX DD: the class action headline looks scarier than the actual facts
$IBRX: Strengthens Balance Sheet With $100 Million Of Financing
Biotech feels brokenโฆ but thatโs usually when things get interesting
$IBRX: Rising CTB, short interest over 30%
25 MATCH 2026 , BIGGEST LOSERS IN THE PRE- MARKET
Iโve been looking at this for over a year now, and now that Iโve got that year behind me, I can stop guessing and look at what actually happened. This is not financial advice. It started as speculation based on real numbers, and now there are real outcomes.
#IBRX ๐ฏ๐๐๐
Investment Advice
Best performing stocks year-to-date by market cap
From the IBRX community on Reddit: $IBRX - IBRX SHORT SQUEEZE ALERT: THE PRESSURE IS MOUNTING. Data driven analysis only based on the screenshots attached.
IBRX Stock: Multi-Year Expansion Roadmap Adds to Endless Run of Gains
$IBRX, Squeeze already started, OPEX today, news for Saudi Arabia this morning. Letโs squeeze the big money. Fuck Cancer
Uncapping a 5/10 call spread โ would you here?
IBRX - YALL - who shorts a life saving company? What evil is that?
Risk-On Does Not Lift Everything. It Lifts the Right Beta Profiles.
$IBRX 135million shares short, 40+ % of the float. Trapped above 8$
What Softer Inflation Does to High Beta Stocks
I anyone here considering IBRX with the newly approved Anktiva aka BioShield for a possible
$IBRX (ImmunityBio) can become the next short-term rocket/long-term investment
$IBRX (ImmunityBio) can become the next short-term rocket/long-term investment
IBRX shorts are fucked!
My opinion on the ongoing IBRX hype (NFA)
LAST CALL: Today is the last day you will ever see IBRX under $6.
All the AI infra stocks testing new all time highs? Its $WYFI time!
WYFI (WhiteFiber) - Low float AI infrastructure play that could squeeze to new all time highs!
WYFI (WhiteFiber) - This low float AI infrastructure play could be set to test new all time highs!
The current math for a parabolic squeeze on IBRX
$IBRX End of day report based on short activity
$IBRX End of day report based on short activity
Is $IBRX โ ๏ธ after latest release? Selling Now or Buying the Dip?
Can't bring my cell into work, but with IBRX at this $$$ I gotta go get my cell and buy some more!
Analyzing the Top Posts on Reddit Last Week
60k IBRX YOLO on WSB they are with us
The treatment for cancer vs shorters (IBRX) BUY BUY BUY
IBRX- ignore the potentual squeeze , buy any dip
Guerilla Tagging - IBRX --- ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ
A Look At ImmunityBio (IBRX) Valuation After FDA Anktiva Pathway And Saudi Approvals - Result: DCF Fair value of $20.93 (UNDERVALUED)
Fuck Cramer/Cancer (Fuck CRANCER)!!! #IBRX TO THE MOON & BEYOND TOMORROW ๐ LET'S HIT USD 15 A PIECE!
Tell me without telling me: is Cramer a sign of good Fortune? Double up on IBRX?
Lets go WSB! Time is now for the next wave! ๐
CMCT up 60% Today on News, High Risk High Reward Buy
Short Sellers Panic As Cancer Cure Drug Skyrockets In Volume
Squeeze radar today (whatโs real pressure vs just talk)
Reddit Ticker Mentions JAN.22.2026 - $NFLX, $IBRX, $SPY, $ASTS, $GORO, $MSFT, $NVDA, $SLS, $VOO, $RIME
Reddit Ticker Mentions JAN.22.2026 - $NFLX, $IBRX, $SPY, $ASTS, $GORO, $MSFT, $NVDA, $SLS, $VOO, $RIME
$IBRX: Friendly Reminder: DISABLE STOCK LENDING ON YOUR ACCOUNT
IBRX to the ๐ still got fuel in the tank
Will IBRX continue the uptrend after 12 days of gains?
ImmunityBio rally causes $492M losses for short sellers (IBRX)
How Can I Beat FOMO In This Market And Stop Buying The Peak/Ceiling?
Ibrx still pumping
IBRX $243M Cash + No IL15 Competitors = Moonshot
Fintel Data and Short Squeeze Update for $IBRX
How The Hell You Degenerates Pick Stocks?
IBRX one month chart: huge volume
IBRX: Fundamentally and Technically Strong
Dr. Pat Soon-Shiong (@DrPatrick) on X - IBRX AI-powered robots ๐ฃ๐ฃ๐ฃ๐ฃ๐ฃ
Trending IBRX, CRVS, NVAX & NUVB Stocks
IBRX saw a random Facebook reel about this company on December 11
7.50$ Surpassed Careful with Stop Losses IBRX
IBRX. A company with FDA approved drug being shorted: nonsense or has any logic?
IBRX?...note for shorters....don't short a FDA approved drug
If POTUS approved IBRX and saves 13k+ lives in the US, he will get my vote for the Nobel Peace Prize...๐คด
If POTUS approved IBRX and saves 13k+ lives in the US, he will get my vote for the Nobel Peace Prize...๐คด
If POTUS approved IBRX and saves 13k+ lives in the US, he will get my vote for the Nobel Peace Prize...๐คด
IBRX We got headlined on Robinhood
IBRX We got headlined on Robinhood - Amazing! Overtime in 4h will be amazing! ๐๐ฃ
IBRX We got headlined on Robinhood
Makes a sense to wait and see when evidence is there? Anktiva from IBRX, question.
oops, or nice, just got notice that my IBRX options were exercised.
Mentions
And I also wonder if there are competitors doing various forms of exactly what IBRX is doing (so technology/drug therapy concept is valid - but - another company is going to do a better job scaling it and proving it out etc). I'd still stick with IBRX but just curious if that is a major aspect that I have overlooked (presence of competitors).
Unfortunately I think youโre caught holding the bag man. Cut your losses now. Iโd full send into IBRX which has short and long term potential. Others have KEEL and ASTS but Iโm not as big into them. NFA
๐ฏโ๏ธ much of traditional finance won't touch it or the interest would be prohibitively high. PSS is assuming the risk at a significant discount which implies a discount to shareholders as well. If IBRX goes bk, PSS stands to lose the most since he's the largest shareholder. He could potentially buy it out of bankruptcy but it's still a loss.
the founder risk is real with IBRX, PSS controls like 90%+ of shares and has a history of overpromising timelines. that doesn't mean the science is bad but it does mean dilution risk is always lurking since they burn cash and have limited revenue. if you're long and convicted, fine, just keep position size small enough that a secondary offering doesn't wreck you. the international approvals are a good sign tbh, just slow to translate to actual revenue.
Long term bag holder here. Almost break even lol. It is a good company. It's somewhat interesting how it has a third the market cap of IBRX with 10x the revenue.
Thanks for the perspective. This is the only biotech stock I own, I bought the majority of my shares back when it was $3 a share. It's a company I've followed for years going back to when it was NantKwest...I otherwise don't invest in this sector. IBRX is a long term speculative bet for me. Curious if by "write options against them" you're referring to writing covered calls? If yes, I've been interested in that but not sure if it's a strategy that still works (even if you're conservative with how you do it). Additionally, when VOO, QQQ, VTSAX etc. are returning 15%-25% (give or take?) over not just a short, but intermediate to long term horizon...I also have a hard time arguing against investing in those, although I worry about whether or not those index funds, given that they track market cap weighted indices like the S&P, are truly as diversified as people think they are.
I agree with the logic. They deleted their comment for some reason, but another commenter characterized it as a highly binary play. Any investment in IBRX has to be speculation (at this time), although I am a believer that the company will scale internationally at a much quicker pace than in the US, due to a faster or more streamlined international regulatory approval process (Saudi Arabia is perhaps evidence of this), and that will drive share appreciation much more so than regulatory approval in the US (given that the FDA requires I think individually approved trials/tests for each and every type of cancer you want to treat). I think bankruptcy risk is mitigated in part by the founder, who has considerable resources, and who has in the past (going back to when it was NantKwest) put his own money into the company several times during periods when it was cash strapped (perhaps similar to what Elon Musk did with Tesla in its earlier years). I always think it's a strong signal (of commitment) when a founder puts his/her own money into their company. Overall though, I could easily fall for the "building too much conviction" trap and I wouldn't consider any of my above comments to be a particularly strong investment thesis.
Guys do you think IBRX has future or should I just take the loss?
Another episode of market bullshit: IBRX is burning through cash, yet only down 2%
Im designed to be a daytrader, scalper to my core self. I never leave my finger from hovering the sell button, unless its a high conviction play like IBRX or various ETFs.
๐๏ธ The FDA Approval Facts ImmunityBio's (NASDAQ: IBRX) flagship immunotherapy, **ANKTIVAยฎ (nogapendekin alfa inbakicept-pmln)**, was officially **approved by the US FDA on April 22, 2024**. \[[1](https://immunitybio.com/immunitybio-announces-fda-approval-of-anktiva-first-in-class-il-15-receptor-agonist-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer/)\] The exact approved indication is for use in combination with Bacillus Calmette-Guรฉrin (BCG) to treat adult patients with **BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS)**, with or without papillary tumors. \[[1](https://immunitybio.com/immunitybio-announces-fda-approval-of-anktiva-first-in-class-il-15-receptor-agonist-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer/)\] * **Current Status (July 2026):** ImmunityBio has an active supplemental Biologics License Application (sBLA) accepted by the FDA to expand the label specifically to **papillary-only disease** without CIS. The FDA has set a PDUFA target action date for this expansion on **January 6, 2027**. \[[1](https://immunitybio.com/immunitybio-announces-fda-acceptance-of-supplemental-bla-for-anktiva-plus-bcg-in-bcg-unresponsive-non-muscle-invasive-bladder-cancer-with-papillary-disease-pdufa-date-set-for-january-6-2027/), [2](https://finance.yahoo.com/sectors/healthcare/articles/fda-accepts-ibrxs-filing-seeking-135300166.html)\] * **Global Expansion:** This follows recent momentum where the United Arab Emirates (UAE) granted marketing authorization for ANKTIVA across both the broad bladder cancer spectrum and metastatic non-small cell lung cancer (NSCLC) Do more research
IBRX up over a UAE permit is equivalent to appointing BugLight's marketing team to wendys
IBRX stock holders too
what happened to $IBRX
IBRX will actually cure cancer but nobody's been ready for that one.
We all know why this was approved. Because it still serves the old gen chemo/radiation business model not really treating cancer while they proudly measure their success in "survival years" - 1-5 years being a surviving in pain ,vomiting zombie is an achievement for them before your body finally shuts down. Every zombie is worth a few hundred thousand grands of insurance money for pharma, that's why they do it. While you have companies like IBRX with proven 70%+ complete REMISSION rate, yet they're being stonewalled on every corner and getting lawsuits from under the microscope. The days of old gen are numbered, every next gen company is now researching immuno therapy approaches and they will hit like tsunami once they hit critical mass where FDA can't deny anymore or they will seek markets outside US as they already do and force FDA's acceptance because their business will fail otherwise. Companies like this are shit and are just riding on old tech.
SLS buyout rumors, IBRX russel 1000 inclusion, SRPT buyout rumors and SPACEX Nasdaq 100 inclusion
Ive been looking it, but im afraid of biotech. Can go down heavily if it doesnt work. Similar to IBRX months ago, hype and then wait
Why not IBRX instead ?
IBRX is not being shy today.
Biotech early plays. $IBRX
Iโve been digging into $IBRX and what stands out is that itโs not another pre-revenue biotech hoping for a breakthrough. They already have an approved commercial product (ANKTIVA), are ramping revenue, expanding internationally, and were recently added to the Russell 1000. Meanwhile Dr. Patrick Soon-Shiong continues to talk about expanding access globally while additional indications and studies move. โฆ IBRX is one of the few that is already generating revenue while still having significant pipeline upside. Worth doing your own DD.
IBRX is another scam
Check out IBRX. Its legally obligated to stay between 6.50 and 8 all yearhaha
When IBRX is up, you know it's all bullshit
Who is still buying IBRX when the FDA will not release an answer until 2027. Dilution coming again before that
Why not IBRX instead ?
I'm in IBRX...another blaster pointed at cancer. "The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory." Lost my mom in '03 to cancer so I love anything that combats it. Gonna take a look at DRTS.
So then what's the play. Full porting IBRX rn
Fine full port IBRX
FP in IBRX for the mean time. That $12 run bound to happen again on news
I would say the market cap (1.7B) is already a bit on the high side for a typical biotech. However, it differs in a few ways from typical biotechs. It's something like 75% retail, where as most are 75% institutions. Tends to make more for pops and drops depending on the results. That said, it does have a very nice TAM and a whole bunch of indications for other cancers as well as a second drug in the pipeline. The drug has a theoretical TAM better than Keytruda, which is a 24B/yr drug. Pharma may put a much higher value than 10-12B on it. In my experience, Phase 3 is usually a pop if successful, but unless I'm playing the buyout game, I'm out before the FDA decision. That one is often priced in. If memory serves, IBRX ran up to about 2B prior to its FDA hearing. Different drug, similar story. It also has a heavy retail presence and currently sits considerably higher than 2B.
IBRX and DRTS holder here....I've been happy with my investments so far!
IBRX $15 price target...LMAO!
My SATL, IBRX, and QUCY swing last week / yesterday set up well. Buying IBRX heavily on this dip as well as OTLK.
[https://www.benzinga.com/pressreleases/26/06/b52918254/immunitybio-presents-new-clinical-and-comparative-data-across-lung-and-bladder-cancer-at-asco-2026](https://www.benzinga.com/pressreleases/26/06/b52918254/immunitybio-presents-new-clinical-and-comparative-data-across-lung-and-bladder-cancer-at-asco-2026) IBRX news
In QUCY and IBRX, why SATL? How much more could it realistically run?
QUCY, SATL, and IBRX are my swing plays I'm setting up for next week
IBRX almost back in my buying range
That is why i asked why not IBRX.. their drug Anktiva works and is expanding worldwide
Why not IBRX instead ?
I would say IBRX
SLS, IBRX, GRPN, COST. I'll gladly take it off your hands as well.
IBRX will be in the $20โs easily and DDD could be between $10-$30. Iโm already collecting 25k annually in divs from F and PFE have a paid off property and renting another out for almost 3k a month thatโs 75k away from being paid off. Iโm thinking yeah, 2030 is pretty realistic based on my current setup but thanks for your projection!
Itโs more DDD and IBRX for me Iโd like to have about 10k of each so I can retire in 2030 when these absolutely are both in double digits again.
IBRX should be pumping soon
Sold my SIDU, SATL, and SPCE and re-entered IBRX at 7.22
IBRX is a steal right now. Price continue to fall after series of good news, trading well below value with solid squeeze set up
Got in 18% today, very well. first on GCTS and then a lil on IBRX
im telling u right now that these Pharma companies r super dangerous. trial makes it it will moon. trail fails this mf going to 0. along the way there is a lot of price manipulation and trickery like today. I dont trust this company and others like IBRX, DRTS for shit. Buy way OTM puts and calls on both sides because these stocks only end up on the extreme side of either.
Opinions on IBRX? It dipped but there was good news. So I bought at 7,40
Time to swing IBRX again soon
I've been in SLS for a long time. But IBRX is still a great swing stock. Easy 10-15% up and down all the time.
I had hopes, but the stock is clearly being manipulated. The chart for IBRX looks terrible now.
Sucks that IBRX did not run on fda news :(
Tempted to give up on IBRX and go for SLS. Chart looks way smoother. SEGG also holding well.
Keeping SLS or sell? Up like 86% on it and am a bit wary of it dropping and stagnating like IBRX lately
I got into DRTS at $7.50 and IBRX at $4.40. Only have about 20 shares of both, but I've been happy with the results!
In for 600 shares $2.18 avg. this and IBRX another solid one.
IBRX is my #1 and only stock now. I cleared out my entire portfolio and went all in.
DFLI earnings did not provide me with any surprises, but because its at ATLโs a minuscule loss, worth the gamble. GLSI is squeezing so I was right about that one, borrow fee is at 210%. Shame I couldnโt do an IBRX style write up on that one as its not a penny. Anyway, Iโve dipped my toe back in pennies this week because of solar/energy, lets see where the market goes following this China visit. NFA
Remember IBRX? (Youโre welcome) Very similar technical set up now happening with GLSI, and I think itโs about to squeeze big time. I would do a write up but itโs not a penny stock unfortunately. One to watch. NFA
IBRX. FDA sanctions, lawsuits and false statements....stock holding steady lol!
In a very strong retort to Jasmine7707 - Iโm sorry but I was providing an update on what I was doing! DXYZ isnโt a low volume penny so unsure why I would need possibly need exit liquidity? Its a SpaceX/Anthropic hype play, looking at the overhangs/NAV does not provide you with the insight into what is an irrational market, my analysis is that people will jump in because of the IPO and send it sky high. Iโve been in since $28 and will sell close to the IPO date. Itโs obviously risky but so was IBRX and that turned out quite well? I myself am unsure as to this posters intentions, and trying making a conspiracy out of my post! I donโt post much here anymore as itโs not a good penny market at the moment.
Welcome back. Are You still hard in IBRX?
IBRX and DRTS are exceptions! I bought IBRX at $4 and DRTS at $5 and they've done well (DRTS less so, but meh).
Cash out and join IBRX
Better buy IBRX
Hereโs how I went from $40 to 400 in a week AMC 1.5c 5/8 GME 24.5p 5/8 SPY 737c 5/8 WYFI 35c 5/15 BTBT 2c 5/15 Iโm not sure if I just take gains and leave, put it in an index fund, or keep gambling on calls because itโs worked out so far what would you do if you were me I have my eye on IBRX or just yolo-ing a 0dte spy call
I've got some IBRX and DRTS, with my eye on RVMD as well. What are your thoughts?
IBRX flew too close to the sun with Dr. Patโs smoking gun IL-15 study road show.
IBRX is about to spike. Check out the Sub
Yeah I wish I had the foresight to predict the next big one...I have a few right now (AVEX, HOVR, ARKX, IBRX), that have huge potential if the stars align
Iโm into IBRX because of my dadโs cancer but also because I see it as a great investment. I really hope that eventually this goes out to all people who need it, also burning FDA and all the shorting market manipulators with them.
As someone who trades this stock with some regularity, there's some question as to whether or not the FDA thing is happening this month or later this year. Note they do have an active reddit site. I do love me some IBRX because it's insanely volatile when it spikes and a bit of a retail meme stock at this point. It has A LOT of retail attention. I will note that one of their big spikes earlier this year was positive earnings, and while they still aren't profitable, they did have a bunch of catalysts last quarter that should impact earnings. I could see them testing 10 or 12 based on that alone given the history of the stock.
[https://www.tradingview.com/news/stocktwits:f99c346f8094b:0/](https://www.tradingview.com/news/stocktwits:f99c346f8094b:0/) IBRX news
ImmunityBio Bio IBRX is appearing more frequently in retail investment discussions lately. Given recent activity, it may be worth reviewing the data to see if it fits your individual strategy. Always do your own due diligence. NFA.
IBRX gimmie that $8
IBRX and INTC are two of the greatest signs of market manipulation